Fig. 3

IPVV levels (A) in healthy controls and T2DM patients, along with their associations with clinical markers (B–G) and HRCT scores (H)
IPVV levels (A) in healthy controls and T2DM patients, along with their associations with clinical markers (B–G) and HRCT scores (H)